APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bupropion Hydrochloride Extended-Release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bupropion Hydrochloride Extended-Release Tablets Market Outlook and Growth Opportunities 2026

31 December 2025199 pages

Choose your research edition.

Industry ResearchBupropion Hydrochloride Extended-Release Tablets Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Bupropion Hydrochloride Extended-Release Tablets Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Bupropion Hydrochloride Extended-Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bupropion Hydrochloride Extended-Release Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Bupropion Hydrochloride Extended-Release Tablets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Bupropion Hydrochloride Extended-Release Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bupropion Hydrochloride Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bupropion Hydrochloride Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bupropion Hydrochloride Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bupropion Hydrochloride Extended-Release Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bupropion Hydrochloride Extended-Release Tablets market include Annora Pharma, Dr. Reddy's, Epic Pharma, Granules India, Impax Laboratories, ProPhase, Teva Pharmaceuticals, Valeant International Barbados SRL and Disha, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bupropion Hydrochloride Extended-Release Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bupropion Hydrochloride Extended-Release Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bupropion Hydrochloride Extended-Release Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bupropion Hydrochloride Extended-Release Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Bupropion Hydrochloride Extended-Release Tablets Segment by Company

Annora Pharma

Dr. Reddy's

Epic Pharma

Granules India

Impax Laboratories

ProPhase

Teva Pharmaceuticals

Valeant International Barbados SRL

Disha

GlaxoSmithKline

Shenyang Funing Pharmaceutical

Venturepharm Pharmacetical

Sinotherapeutics

Yichang Humanwell Pharmaceutical

Bupropion Hydrochloride Extended-Release Tablets Segment by Type

150mg

300mg

Bupropion Hydrochloride Extended-Release Tablets Segment by Application

Pharmacy

Hospital

Clinic

Bupropion Hydrochloride Extended-Release Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Bupropion Hydrochloride Extended-Release Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bupropion Hydrochloride Extended-Release Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bupropion Hydrochloride Extended-Release Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Bupropion Hydrochloride Extended-Release Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bupropion Hydrochloride Extended-Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bupropion Hydrochloride Extended-Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bupropion Hydrochloride Extended-Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bupropion Hydrochloride Extended-Release Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bupropion Hydrochloride Extended-Release Tablets industry.

Chapter 3: Detailed analysis of Bupropion Hydrochloride Extended-Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bupropion Hydrochloride Extended-Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bupropion Hydrochloride Extended-Release Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bupropion Hydrochloride Extended-Release Tablets Industry Trends Table 2. Bupropion Hydrochloride Extended-Release Tablets Industry Drivers Table 3. Bupropion Hydrochloride Extended-Release Tablets Industry Opportunities and Challenges Table 4. Bupropion Hydrochloride Extended-Release Tablets Industry Restraints Table 5. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Share by Company (2021-2026) Table 7. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Company (Units) & (2021-2026) Table 8. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Bupropion Hydrochloride Extended-Release Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Bupropion Hydrochloride Extended-Release Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bupropion Hydrochloride Extended-Release Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Bupropion Hydrochloride Extended-Release Tablets Company, Product Type & Application Table 13. Global Bupropion Hydrochloride Extended-Release Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bupropion Hydrochloride Extended-Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 150mg Table 18. Significant Companies of 300mg Table 19. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Type (2021-2026) & (Units) Table 21. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Type (2027-2032) & (Units) Table 22. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type (2021-2026) Table 28. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmacy Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Application (2021-2026) & (Units) Table 34. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Application (2027-2032) & (Units) Table 35. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application (2021-2026) Table 41. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application (2027-2032) Table 42. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region (2021-2026) & (Units) Table 44. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Region (2021-2026) Table 45. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region (2027-2032) & (Units) Table 46. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Region (2027-2032) Table 47. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Region (2021-2026) Table 50. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Region (2027-2032) Table 52. Global Bupropion Hydrochloride Extended-Release Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Bupropion Hydrochloride Extended-Release Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2026) & (Units) Table 57. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Country (2021-2026) Table 58. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2027-2032) & (Units) Table 59. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Country (2027-2032) Table 60. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Market Share by Country (2027-2032) Table 64. Annora Pharma Company Information Table 65. Annora Pharma Business Overview Table 66. Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 68. Annora Pharma Recent Development Table 69. Dr. Reddy's Company Information Table 70. Dr. Reddy's Business Overview Table 71. Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 73. Dr. Reddy's Recent Development Table 74. Epic Pharma Company Information Table 75. Epic Pharma Business Overview Table 76. Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 78. Epic Pharma Recent Development Table 79. Granules India Company Information Table 80. Granules India Business Overview Table 81. Granules India Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Granules India Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 83. Granules India Recent Development Table 84. Impax Laboratories Company Information Table 85. Impax Laboratories Business Overview Table 86. Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 88. Impax Laboratories Recent Development Table 89. ProPhase Company Information Table 90. ProPhase Business Overview Table 91. ProPhase Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. ProPhase Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 93. ProPhase Recent Development Table 94. Teva Pharmaceuticals Company Information Table 95. Teva Pharmaceuticals Business Overview Table 96. Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 98. Teva Pharmaceuticals Recent Development Table 99. Valeant International Barbados SRL Company Information Table 100. Valeant International Barbados SRL Business Overview Table 101. Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 103. Valeant International Barbados SRL Recent Development Table 104. Disha Company Information Table 105. Disha Business Overview Table 106. Disha Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Disha Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 108. Disha Recent Development Table 109. GlaxoSmithKline Company Information Table 110. GlaxoSmithKline Business Overview Table 111. GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 113. GlaxoSmithKline Recent Development Table 114. Shenyang Funing Pharmaceutical Company Information Table 115. Shenyang Funing Pharmaceutical Business Overview Table 116. Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 118. Shenyang Funing Pharmaceutical Recent Development Table 119. Venturepharm Pharmacetical Company Information Table 120. Venturepharm Pharmacetical Business Overview Table 121. Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 123. Venturepharm Pharmacetical Recent Development Table 124. Sinotherapeutics Company Information Table 125. Sinotherapeutics Business Overview Table 126. Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 128. Sinotherapeutics Recent Development Table 129. Yichang Humanwell Pharmaceutical Company Information Table 130. Yichang Humanwell Pharmaceutical Business Overview Table 131. Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 133. Yichang Humanwell Pharmaceutical Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Bupropion Hydrochloride Extended-Release Tablets Distributors List Table 137. Bupropion Hydrochloride Extended-Release Tablets Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Bupropion Hydrochloride Extended-Release Tablets Product Image Figure 2. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bupropion Hydrochloride Extended-Release Tablets Sales (2021-2032) & (Units) Figure 5. Global Bupropion Hydrochloride Extended-Release Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Bupropion Hydrochloride Extended-Release Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 150mg Image Figure 10. 300mg Image Figure 11. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type (2021-2032) Figure 17. Pharmacy Image Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 27. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Bupropion Hydrochloride Extended-Release Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Bupropion Hydrochloride Extended-Release Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg
  • 300mg
Applications
  • Pharmacy
  • Hospital
  • Clinic
Companies covered
  • Annora Pharma
  • Dr. Reddy's
  • Epic Pharma
  • Granules India
  • Impax Laboratories
  • ProPhase
  • Teva Pharmaceuticals
  • Valeant International Barbados SRL
  • Disha
  • GlaxoSmithKline
  • Shenyang Funing Pharmaceutical
  • Venturepharm Pharmacetical
  • Sinotherapeutics
  • Yichang Humanwell Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bupropion Hydrochloride Extended-Release Tablets Market Dynamics
  1. 2.1 Bupropion Hydrochloride Extended-Release Tablets Industry Trends
  2. 2.2 Bupropion Hydrochloride Extended-Release Tablets Industry Drivers
  3. 2.3 Bupropion Hydrochloride Extended-Release Tablets Industry Opportunities and Challenges
  4. 2.4 Bupropion Hydrochloride Extended-Release Tablets Industry Restraints
3 Bupropion Hydrochloride Extended-Release Tablets Market by Company
  1. 3.1 Global Bupropion Hydrochloride Extended-Release Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Bupropion Hydrochloride Extended-Release Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Bupropion Hydrochloride Extended-Release Tablets Company Ranking (2024-2026)
  6. 3.6 Global Bupropion Hydrochloride Extended-Release Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Bupropion Hydrochloride Extended-Release Tablets Company Product Type and Application
  8. 3.8 Global Bupropion Hydrochloride Extended-Release Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bupropion Hydrochloride Extended-Release Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bupropion Hydrochloride Extended-Release Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bupropion Hydrochloride Extended-Release Tablets Market by Type
  1. 4.1 Bupropion Hydrochloride Extended-Release Tablets Type Introduction
  2. 4.1.1 150mg
  3. 4.1.2 300mg
  4. 4.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Type
  5. 4.2.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Type
  9. 4.3.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type (2021-2032)
5 Bupropion Hydrochloride Extended-Release Tablets Market by Application
  1. 5.1 Bupropion Hydrochloride Extended-Release Tablets Application Introduction
  2. 5.1.1 Pharmacy
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Application
  6. 5.2.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Application
  10. 5.3.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application (2021-2032)
6 Bupropion Hydrochloride Extended-Release Tablets Regional Sales and Value Analysis
  1. 6.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region (2027-2032)
  5. 6.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Bupropion Hydrochloride Extended-Release Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bupropion Hydrochloride Extended-Release Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Country, 2025 VS 2032
7 Bupropion Hydrochloride Extended-Release Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2027-2032)
  6. 7.4 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bupropion Hydrochloride Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bupropion Hydrochloride Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Annora Pharma
  2. 8.1.1 Annora Pharma Company Information
  3. 8.1.2 Annora Pharma Business Overview
  4. 8.1.3 Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  6. 8.1.5 Annora Pharma Recent Developments
  7. 8.2 Dr. Reddy's
  8. 8.2.1 Dr. Reddy's Company Information
  9. 8.2.2 Dr. Reddy's Business Overview
  10. 8.2.3 Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  12. 8.2.5 Dr. Reddy's Recent Developments
  13. 8.3 Epic Pharma
  14. 8.3.1 Epic Pharma Company Information
  15. 8.3.2 Epic Pharma Business Overview
  16. 8.3.3 Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  18. 8.3.5 Epic Pharma Recent Developments
  19. 8.4 Granules India
  20. 8.4.1 Granules India Company Information
  21. 8.4.2 Granules India Business Overview
  22. 8.4.3 Granules India Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Granules India Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  24. 8.4.5 Granules India Recent Developments
  25. 8.5 Impax Laboratories
  26. 8.5.1 Impax Laboratories Company Information
  27. 8.5.2 Impax Laboratories Business Overview
  28. 8.5.3 Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  30. 8.5.5 Impax Laboratories Recent Developments
  31. 8.6 ProPhase
  32. 8.6.1 ProPhase Company Information
  33. 8.6.2 ProPhase Business Overview
  34. 8.6.3 ProPhase Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 ProPhase Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  36. 8.6.5 ProPhase Recent Developments
  37. 8.7 Teva Pharmaceuticals
  38. 8.7.1 Teva Pharmaceuticals Company Information
  39. 8.7.2 Teva Pharmaceuticals Business Overview
  40. 8.7.3 Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  42. 8.7.5 Teva Pharmaceuticals Recent Developments
  43. 8.8 Valeant International Barbados SRL
  44. 8.8.1 Valeant International Barbados SRL Company Information
  45. 8.8.2 Valeant International Barbados SRL Business Overview
  46. 8.8.3 Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  48. 8.8.5 Valeant International Barbados SRL Recent Developments
  49. 8.9 Disha
  50. 8.9.1 Disha Company Information
  51. 8.9.2 Disha Business Overview
  52. 8.9.3 Disha Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Disha Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  54. 8.9.5 Disha Recent Developments
  55. 8.10 GlaxoSmithKline
  56. 8.10.1 GlaxoSmithKline Company Information
  57. 8.10.2 GlaxoSmithKline Business Overview
  58. 8.10.3 GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  60. 8.10.5 GlaxoSmithKline Recent Developments
  61. 8.11 Shenyang Funing Pharmaceutical
  62. 8.11.1 Shenyang Funing Pharmaceutical Company Information
  63. 8.11.2 Shenyang Funing Pharmaceutical Business Overview
  64. 8.11.3 Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  66. 8.11.5 Shenyang Funing Pharmaceutical Recent Developments
  67. 8.12 Venturepharm Pharmacetical
  68. 8.12.1 Venturepharm Pharmacetical Company Information
  69. 8.12.2 Venturepharm Pharmacetical Business Overview
  70. 8.12.3 Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  72. 8.12.5 Venturepharm Pharmacetical Recent Developments
  73. 8.13 Sinotherapeutics
  74. 8.13.1 Sinotherapeutics Company Information
  75. 8.13.2 Sinotherapeutics Business Overview
  76. 8.13.3 Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  78. 8.13.5 Sinotherapeutics Recent Developments
  79. 8.14 Yichang Humanwell Pharmaceutical
  80. 8.14.1 Yichang Humanwell Pharmaceutical Company Information
  81. 8.14.2 Yichang Humanwell Pharmaceutical Business Overview
  82. 8.14.3 Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  84. 8.14.5 Yichang Humanwell Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bupropion Hydrochloride Extended-Release Tablets Value Chain Analysis
  2. 9.1.1 Bupropion Hydrochloride Extended-Release Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bupropion Hydrochloride Extended-Release Tablets Sales Mode & Process
  6. 9.2 Bupropion Hydrochloride Extended-Release Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bupropion Hydrochloride Extended-Release Tablets Distributors
  9. 9.2.3 Bupropion Hydrochloride Extended-Release Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst